Creyon Bio
PrivateLast Round
Strategic
Apr 29, 2025
Total Funding Raised
$40M
Company Overview
Creyon Bio is a biotechnology company that develops RNA-based medicines and their components using a data-first approach with machine learning models.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Medical AI, Precision Medicine
Business Model
B2B
Customer Profile
Revenue Share, Services & Consulting
AI Layer
Infrastructure
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Creyon Bio Comps
Public and private peers based on sector, stage, and business model.
Creyon Bio Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Strategic | Apr 29, 2025 | ||||
| Seed | Mar 8, 2022 |
Key People
Founding team and executive leadership
Creyon Bio Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| DCVC Bio | Seed |
| Lux Capital | Seed |
| Alexandria Venture Investments | Seed |
| BioBrit | Seed |
| Casdin Capital | Seed |
Market signals
Structured signals derived from secondary market and firmographic data.
- Apr 29, 2025
Completed a strategic funding round.
- Mar 8, 2022
$40M raised in Seed round.
Creyon Bio Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Creyon Bio's valuation, stock price, and market status.
